Back

Targeting BRD4-HK2 reverses the meta-inflammatory shift in perivascular adipose tissue and rescues cardiometabolic vascular dysfunction.

1 September 2024 (09:30 - 09:40)
Organised by: Logo
Congress Presentation Part of: Epigenetic targets in cardiovascular disease Vascular Diseases ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Alessandro Mengozzi

University of Pisa, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Chromatin remodeling by the histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction
Doctor S. Costantino (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Epigenetic BET inhibitor apabetalone counters inflammatory and fibrotic processes in activated cardiac fibroblasts providing insight into reduced hospitalizations for heart failure in BETonMACE trial
Doctor E. Kulikowski (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
The BET inhibitor Apabetalone protects against heart failure with preserved ejection fraction by suppressing myocardial inflammation
Doctor E. Gorica (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
RBM20 promotes doxorubicin-induced cardiotoxicity by Atp6v0a1 alternative splicing
Doctor Z. Qiu (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Epigenetic targets in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 09:30 CET
You may be interested in
thumbnail
Congress Presentation
BET protein inhibition rewires the vascular-fat interface in cardiometabolic disease
thumbnail
Congress Presentation
Emerging therapies to prevent perivascular fat dysfunction in cardiometabolic heart failure
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources